Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2010-01-10 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAVERDUN (09700), Ariege
SELARL PHARMACIE DE SAVERDUN : revenue, balance sheet and financial ratios
SELARL PHARMACIE DE SAVERDUN is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAVERDUN (09700),
this company of category PME
shows in 2022 a revenue of 4.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DE SAVERDUN (SIREN 529489999)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
4 361 407 €
4 104 719 €
3 768 370 €
3 793 330 €
3 560 048 €
3 489 901 €
N/C
Net income
330 536 €
339 653 €
225 033 €
296 671 €
219 053 €
219 200 €
196 305 €
204 144 €
182 422 €
EBITDA
N/C
N/C
329 036 €
425 912 €
330 556 €
328 749 €
292 853 €
326 306 €
-2 977 974 €
Net margin
N/C
N/C
5.2%
7.2%
5.8%
5.8%
5.5%
5.8%
N/C
Revenue and income statement
In 2024, SELARL PHARMACIE DE SAVERDUN generates positive net income of 331 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 182 k€ -> 331 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
330 536 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 118%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 41%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
117.527%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
41.228%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DE SAVERDUN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
150.377
110.554
81.323
58.606
42.189
23.336
418.964
197.621
117.527
Financial autonomy
35.381
41.537
49.874
55.557
61.934
69.662
16.517
28.562
41.228
Repayment capacity
8.651
6.305
5.761
4.058
3.239
1.576
8.604
None
None
Cash flow / Revenue
14215.855%
6.444%
5.747%
6.238%
6.317%
7.556%
5.427%
None%
None%
Sector positioning
Debt ratio
117.532024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average-10 pts over 3 years
In 2024, the debt ratio of SELARL PHARMACIE DE SAVERDUN (117.53) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
41.23%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+15 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE DE SAVERDUN (41.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
8.6 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of SELARL PHARMACIE DE SAVERDUN (8.60) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 299.27. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
299.275
Liquidity indicators evolution SELARL PHARMACIE DE SAVERDUN
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
286.218
256.799
298.54
253.234
255.974
229.616
216.696
223.932
299.275
Interest coverage
-2.433
6.713
6.376
4.69
3.671
2.077
1.707
None
None
Sector positioning
Liquidity ratio
299.272024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Excellent+19 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE DE SAVERDUN (299.27) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
1.71x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of SELARL PHARMACIE DE SAVERDUN (1.7x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE DE SAVERDUN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
0 €
209 952 €
249 631 €
231 772 €
173 345 €
130 120 €
244 762 €
0 €
0 €
Inventory turnover (days)
0
25
23
24
23
22
18
0
0
Customer payment term (days)
0
0
0
0
0
1
0
0
0
Supplier payment term (days)
41
43
31
35
32
31
40
0
0
Positioning of SELARL PHARMACIE DE SAVERDUN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE DE SAVERDUN is estimated at
4 614 526 €
(range 3 213 483€ - 6 903 596€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
3213k€4614k€6903k€
4 614 526 €Range: 3 213 483€ - 6 903 596€
NAF 5 année 2024
Valuation method used
Net Income Multiple
330 536 €
×
14.0x
=4 614 527 €
Range: 3 213 484€ - 6 903 596€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DE SAVERDUN with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DE SAVERDUN
What is the revenue of SELARL PHARMACIE DE SAVERDUN ?
The revenue of SELARL PHARMACIE DE SAVERDUN in 2022 is 4.4 M€.
Is SELARL PHARMACIE DE SAVERDUN profitable?
Yes, SELARL PHARMACIE DE SAVERDUN generated a net profit of 331 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE DE SAVERDUN ?
The headquarters of SELARL PHARMACIE DE SAVERDUN is located in SAVERDUN (09700), in the department Ariege.
Where to find the tax return of SELARL PHARMACIE DE SAVERDUN ?
The tax return of SELARL PHARMACIE DE SAVERDUN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DE SAVERDUN operate?
SELARL PHARMACIE DE SAVERDUN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart